Alan Colowick - Profile and Investment Details

Investor Profile

Alan Colowick is a Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as ENYO Pharma, Y-mAbs Therapeutics, NuCana, Gloucester Pharmaceuticals, Histogenics, Amplyx Pharmaceuticals, Sorbent Therapeutics, Anumana, Matrix Capital Management Company, L.P., AltPep, Visen Pharmaceuticals, nference, Versartis, Auris Medical, Aerovate Therapeutics, Medeor Therapeutics, GuavusEdge Therapeutics, NorthSea Therapeutics, Athira Pharma, Ascendis Pharma, Audentes Therapeutics, CinCor Pharma, Karuna Therapeutics, Bolt Biotherapeutics, Harpoon Therapeutics, Pramana, Vestagen Technical Textiles, Velos Biopharma, InCarda Therapeutics, Ziarco, Pionyr Immunotherapeutics, Invitae, AFYX Therapeutics, XyloCor Therapeutics, Natera, LYSOGENE, Neurana Pharmaceuticals, Kiniksa Pharmaceuticals, Aeovian Pharmaceuticals, Personalis, Inc., Principia Biopharma, Solve Therapeutics, Inc., Innocoll Holdings, Quanta Therapeutics, AC Immune, NuCana BioMed, ZS Pharma, NextCure, Maze Therapeutics, ConteXtream, Chiasma, Alumis, Aclaris Therapeutics, Vera Therapeutics, Checkmate Pharmaceuticals, First Aid Shot Therapy, Apellis Pharmaceuticals, ACELYRIN, INC., McPhy, Civitas Therapeutics, Crocus Technology, Atsena Therapeutics, Human Longevity, Inc., Rainier Therapeutics, Galera Therapeutics, Gyroscope Therapeutics, VelosBio, Antiva Biosciences, Intrepida Bio, Merus, Mirna Therapeutics, Akouos, Coherus Biosciences, Achaogen Inc, Dimension Therapeutics, aTyr Pharma, Inozyme, ReCode Therapeutics, Promedior, Iterum Therapeutics, XyloCor Therapeutics, Inc., ObsEva, Dauntless Pharmaceuticals, Spark Therapeutics, Entasis Therapeutics, . Over time, Alan Colowick has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alan Colowick is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Investment Management, Life Science, Biotechnology, Genomics, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Alan Colowick, as their portfolio suggests a familiarity and interest in this area.

Understanding Alan Colowick’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.